Evidence map›Paper›PMID 40013074›Full record

ArticleDigital health

Structuring and centralizing breast cancer real-world biomarker data from pathology reports through C-LAB

Florent Le Borgne, Camille Garnier, Camille Morisseau, Yanis Navarrete, Yanina Echeverria, Juan Mir, Jaume Calafell, Tanguy Perennec, Olivier Kerdraon, Jean-Sébastien Frenel and 4 more

Abstract read
In one paragraph

Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Florent Le BorgneData Factory & Analytics Department, Institut de Cancérologie de l'Ouest, Nantes-Angers, France.ORCID https://orcid.org/0000-0003-2361-1608
Camille GarnierConnect By Circular Lab, Madrid, Spain.
Camille MorisseauData Factory & Analytics Department, Institut de Cancérologie de l'Ouest, Nantes-Angers, France.
Yanis NavarreteConnect By Circular Lab, Madrid, Spain.
Yanina EcheverriaConnect By Circular Lab, Madrid, Spain.
Juan MirConnect By Circular Lab, Madrid, Spain.
Jaume CalafellConnect By Circular Lab, Madrid, Spain.
Tanguy PerennecDepartment of Radiation Oncology, Institut de Cancérologie de l'Ouest, Nantes-Angers, France.
Olivier KerdraonDepartment of Pathology, Institut de Cancérologie de l'Ouest, Nantes-Angers, France.
Jean-Sébastien FrenelOncology Department, Institut de Cancérologie de l'Ouest, Nantes-Angers, France.
Judith RaimbourgOncology Department, Institut de Cancérologie de l'Ouest, Nantes-Angers, France.
Mario CamponeOncology Department, Institut de Cancérologie de l'Ouest, Nantes-Angers, France.
Maria Fe PazConnect By Circular Lab, Madrid, Spain.
François BocquetData Factory & Analytics Department, Institut de Cancérologie de l'Ouest, Nantes-Angers, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To evaluate the effectiveness of C-LAB Methods: C-LAB Results: C-LAB Conclusion: AI technologies like C-LAB

Indexed as

artificial intelligence generalbiomarkerCancer diseasegenetics medicinemachine learning generaloncology medicine

Identifiers

PMID40013074
PMCPMC11863259

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.